Delivery details Location not set Select delivery location Delivery by 9 Aug, Sun Fulfilled by Plix 4.1 5 years with Flipkart See other sellers No returns Cash on Delivery Flipkart Assured Add to cart Buy at 2,279 Similar Products AD 4.1 The Plant Fix Plix Glowy Skin Tablets With 500mg Glutathione & Vitamin C | Watermelon 2 x 15 No 25% OFF 1,150 863 788 with 2 offers Get it by 8 Aug AD Trending 4.1 The Plant Fix Plix Glutathione Skin Glow Effervescent Tablet 500mg for Clear & Youthful Skin 15 No 24% OFF 575 439 364 with 2 offers Get it by 4 Aug 4.3 The Plant Fix Plix Glowy Skin Tablets | 500mg L-Glutathione & Vitamin C | Pack Of 4, Grape 4 x 15 Tablets 33% OFF 2,310 1,559 1,481 with 2 offers AD 4.3 The Plant Fix Plix ACV Hot Brew Effervescent | Metabolism & Immunity Support (Ginger Nutmeg) 15 Tablets 60% OFF 350 140 Hot Deal Get it by 4 Aug AD Trending 4 Chicnutrix Glow - Japanese OPITAC Glutathione & Vitamin C for bright & even skin 10 Tablets 27% OFF 699 509 Hot Deal Get it by 4 Aug AD 4.1 The Plant Fix Plix Apple Cider Vinegar Effervescent Tablet | With Mother | 750mg ACV 4 x 15 Tablets 36% OFF 1,440 919 844 with 2 offers Get it by 4 Aug AD 4 The Plant Fix Plix ACV Hot Brew Effervescent | Metabolism & Immunity Support (Apple Cinnamon) 4 x 15 Tablets 36% OFF 1,400 903 828 with 2 offers Get it by 4 Aug AD Bestseller 4.2 The Plant Fix Plix Apple Cider Vinegar 15 Effervescent Tablets Watermelon Flavour with Vitamin B12 2 x 15 No 23% OFF 620 479 404 with 2 offers Get it by 4 Aug Hang on, loading content
Detoxifies the Skin : Detoxifies the skin by eliminating free radicals and reducing liver toxicity, contributing to healthier skin, nails, and hair
Cells throughout the body can also produce smaller amounts to meet local needs
It is offered as a wellness service, not a medical treatment for any disease
Safety concerns Several scientific papers have established the benefits of glutathione in treating some chronic medical conditions, as earlier highlighted
Lack of Combination Studies and Human Clinical Data The most significant limitation is the complete absence of controlled research on the combination itself: No peer-reviewed combination studies exist in any species or model No controlled experiments examining synergy, antagonism, or interaction effects All combination data derived from anecdotal clinical observations without controls No human clinical trials for either peptide individually or in combination Human safety profile completely unestablished for the combination Optimal dosing ratios and total doses unknown Long-term effects in any species unstudied for the combination Mechanistic Understanding Gaps Fundamental aspects of how these peptides might interact remain unclear: Receptor interactions between BPC-157 and TB-500 pathways uncharacterized Whether combined administration creates additive, synergistic, or antagonistic effects unknown Potential for competition at shared pathways (both affect angiogenesis) not investigated Pharmacokinetic interactions unexplored Metabolic interference possibilities unexamined Long-Term Safety Considerations Critical safety questions remain unanswered for both individual peptides and especially their combination: Chronic use effects beyond several weeks unstudied even in animals Potential for uncontrolled angiogenesis (cancer promotion) with dual pro-angiogenic peptides uninvestigated Combined effects on tumor growth or metastasis unknown Interaction potential with medications uncharacterized Reproductive and developmental toxicity inadequately studied for either peptide Long-term consequences of enhanced cellular migration capacity unexplored Regulatory & Competitive Sport Status FDA Position Neither BPC-157 nor TB-500 has received FDA approval for any indication, and their combination lacks regulatory recognition: Both peptides classified as unapproved drug substances Not recognized as GRAS (Generally Recognized as Safe) Not approved for human or veterinary use Not legally available for medical compounding in the United States FDA has issued warning letters to companies marketing BPC-157 for human use No established therapeutic use basis for either peptide or their combination The FDA has specifically stated that compounded drugs containing BPC-157 may cause immune system reactions, with insufficient data to assess human safety
